|
2024-01-08 |
2024-01-05 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
CHIEF SCIENTIFIC OFFICER
Führungsperson
|
898
-3.1%
22,78
20.456 USD
|
898
-3.1%
|
22,78
|
20.456 USD
|
|
|
2023-12-22 |
2023-12-21 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
2.500
-14.3%
21,68
54.200 USD
|
2.500
-14.3%
|
21,68
|
54.200 USD
|
|
|
2023-11-29 |
2023-11-28 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
1.500
-7.9%
13,72
20.580 USD
|
1.500
-7.9%
|
13,72
|
20.580 USD
|
|
|
2023-10-04 |
2023-10-03 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
2.500
-11.7%
15,77
39.425 USD
|
2.500
-11.7%
|
15,77
|
39.425 USD
|
|
|
2023-08-22 |
2023-08-18 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
2.500
-10.5%
18,92
47.300 USD
|
2.500
-10.5%
|
18,92
|
47.300 USD
|
|
|
2023-04-20 |
2023-04-19 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
5.000
-19.2%
18,88
94.400 USD
|
5.000
-19.2%
|
18,88
|
94.400 USD
|
|
|
2023-03-15 |
2023-03-14 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.500
+62.5%
20,05
50.125 USD
|
2.500
+62.5%
|
20,05
|
50.125 USD
|
|
|
2023-03-15 |
2023-03-14 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
600
+4.2%
19,95
11.970 USD
|
600
+4.2%
|
19,95
|
11.970 USD
|
|
|
2023-03-15 |
2023-03-14 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
400
+2.9%
18,48
7.392 USD
|
400
+2.9%
|
18,48
|
7.392 USD
|
|
|
2023-03-15 |
2023-03-14 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.500
+12.1%
18,75
28.125 USD
|
1.500
+12.1%
|
18,75
|
28.125 USD
|
|
|
2023-03-13 |
2023-03-07 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
5.000
-16.4%
29,62
148.100 USD
|
5.000
-16.4%
|
29,62
|
148.100 USD
|
|
|
2023-01-26 |
2023-01-24 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
5.000
-14.3%
30,00
150.000 USD
|
5.000
-14.3%
|
30,00
|
150.000 USD
|
|
|
2023-01-20 |
2023-01-19 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
5.000
-12.5%
25,56
127.800 USD
|
5.000
-12.5%
|
25,56
|
127.800 USD
|
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
742
-3.7%
21,97
16.299 USD
|
742
-3.7%
|
21,97
|
16.299 USD
|
|
|
2022-12-30 |
2022-12-29 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
5.000
-11.7%
18,03
90.150 USD
|
5.000
-11.7%
|
18,03
|
90.150 USD
|
|
|
2022-11-29 |
2022-11-28 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
5.000
-10.5%
17,87
89.350 USD
|
5.000
-10.5%
|
17,87
|
89.350 USD
|
|
|
2022-11-03 |
2022-11-02 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
5.000
-9.5%
22,32
111.600 USD
|
5.000
-9.5%
|
22,32
|
111.600 USD
|
|
|
2022-10-14 |
2022-10-13 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
2.000
-3.7%
21,52
43.040 USD
|
2.000
-3.7%
|
21,52
|
43.040 USD
|
|
|
2022-08-31 |
2022-08-30 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
2.500
-4.5%
28,13
70.325 USD
|
2.500
-4.5%
|
28,13
|
70.325 USD
|
|
|
2022-07-13 |
2022-07-11 |
V
Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
2.000
-3.7%
19,95
39.900 USD
|
2.000
-3.7%
|
19,95
|
39.900 USD
|
|
|
2022-05-27 |
2022-05-25 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
63
+0.1%
12,45
785 USD
|
63
+0.1%
|
12,45
|
785 USD
|
|
|
2022-05-27 |
2022-05-25 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
1.837
+0.1%
12,45
22.880 USD
|
1.837
+0.1%
|
12,45
|
22.880 USD
|
|
|
2022-05-27 |
2022-05-25 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
63
+0.1%
12,45
785 USD
|
63
+0.1%
|
12,45
|
785 USD
|
|
|
2022-05-27 |
2022-05-25 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
1.837
+0.1%
12,45
22.880 USD
|
1.837
+0.1%
|
12,45
|
22.880 USD
|
|
|
2022-05-25 |
2022-05-24 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
538
+1.3%
12,00
6.457 USD
|
538
+1.3%
|
12,00
|
6.457 USD
|
|
|
2022-05-25 |
2022-05-24 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
15.776
+1.3%
12,00
189.345 USD
|
15.776
+1.3%
|
12,00
|
189.345 USD
|
|
|
2022-05-25 |
2022-05-24 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
538
+1.3%
12,00
6.457 USD
|
538
+1.3%
|
12,00
|
6.457 USD
|
|
|
2022-05-25 |
2022-05-24 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
15.776
+1.3%
12,00
189.345 USD
|
15.776
+1.3%
|
12,00
|
189.345 USD
|
|
|
2022-05-25 |
2022-05-23 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
338
+0.8%
12,50
4.225 USD
|
338
+0.8%
|
12,50
|
4.225 USD
|
|
|
2022-05-25 |
2022-05-23 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
9.898
+0.8%
12,50
123.718 USD
|
9.898
+0.8%
|
12,50
|
123.718 USD
|
|
|
2022-05-25 |
2022-05-23 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
338
+0.8%
12,50
4.225 USD
|
338
+0.8%
|
12,50
|
4.225 USD
|
|
|
2022-05-25 |
2022-05-23 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
9.898
+0.8%
12,50
123.718 USD
|
9.898
+0.8%
|
12,50
|
123.718 USD
|
|
|
2022-05-12 |
2022-05-10 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
41.250
+inf%
10,67
440.199 USD
|
41.250
+inf%
|
10,67
|
440.199 USD
|
|
|
2022-05-12 |
2022-05-10 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
1.208.750
+inf%
10,67
12.899.176 USD
|
1.208.750
+inf%
|
10,67
|
12.899.176 USD
|
|
|
2022-05-12 |
2022-05-10 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
400
+11.1%
10,62
4.248 USD
|
400
+11.1%
|
10,62
|
4.248 USD
|
|
|
2022-05-12 |
2022-05-10 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
600
+20.0%
10,49
6.294 USD
|
600
+20.0%
|
10,49
|
6.294 USD
|
|
|
2022-05-12 |
2022-05-10 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.000
+50.0%
10,51
10.510 USD
|
1.000
+50.0%
|
10,51
|
10.510 USD
|
|
|
2022-05-12 |
2022-05-10 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
500
+38.5%
11,30
5.650 USD
|
500
+38.5%
|
11,30
|
5.650 USD
|
|
|
2022-05-12 |
2022-05-10 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.500
+22.1%
11,80
29.500 USD
|
2.500
+22.1%
|
11,80
|
29.500 USD
|
|
|
2022-05-12 |
2022-05-10 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.000
+21.5%
10,54
21.080 USD
|
2.000
+21.5%
|
10,54
|
21.080 USD
|
|
|
2022-05-12 |
2022-05-10 |
GK
Geplanter Kauf
|
Young Rodney KB
Chief Financial Officer
Führungsperson
|
5.000
+98.3%
10,53
52.650 USD
|
5.000
+98.3%
|
10,53
|
52.650 USD
|
|
|
2022-05-12 |
2022-05-10 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
41.250
+inf%
10,67
440.199 USD
|
41.250
+inf%
|
10,67
|
440.199 USD
|
|
|
2022-05-12 |
2022-05-10 |
K
Kauf
|
COLUMN GROUP II, LP
Large shareholder
|
1.208.750
+inf%
10,67
12.899.176 USD
|
1.208.750
+inf%
|
10,67
|
12.899.176 USD
|
|
|
2022-05-05 |
2022-05-04 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
720
-3.5%
15,05
10.836 USD
|
720
-3.5%
|
15,05
|
10.836 USD
|
|
|
2022-04-12 |
2022-04-11 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
2.647
-11.8%
23,05
61.013 USD
|
2.647
-11.8%
|
23,05
|
61.013 USD
|
|
|
2022-04-07 |
2022-04-06 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
3.000
-5.3%
22,96
68.880 USD
|
3.000
-5.3%
|
22,96
|
68.880 USD
|
|
|
2022-03-14 |
2022-03-11 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
2.648
-11.8%
23,91
63.314 USD
|
2.648
-11.8%
|
23,91
|
63.314 USD
|
|
|
2022-02-28 |
2022-02-28 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
3.000
-5.1%
18,79
56.370 USD
|
3.000
-5.1%
|
18,79
|
56.370 USD
|
|
|
2022-02-14 |
2022-02-11 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
2.647
-11.8%
22,47
59.478 USD
|
2.647
-11.8%
|
22,47
|
59.478 USD
|
|
|
2022-01-14 |
2022-01-13 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
3.000
-4.9%
30,67
92.010 USD
|
3.000
-4.9%
|
30,67
|
92.010 USD
|
|
|
2022-01-13 |
2022-01-11 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
2.648
-11.8%
32,16
85.160 USD
|
2.648
-11.8%
|
32,16
|
85.160 USD
|
|
|
2022-01-06 |
2022-01-05 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
2.000
-3.2%
40,00
80.000 USD
|
2.000
-3.2%
|
40,00
|
80.000 USD
|
|
|
2021-12-13 |
2021-12-10 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
2.647
-11.8%
30,88
81.739 USD
|
2.647
-11.8%
|
30,88
|
81.739 USD
|
|
|
2021-12-06 |
2021-12-03 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
3.000
-5.0%
32,26
96.780 USD
|
3.000
-5.0%
|
32,26
|
96.780 USD
|
|
|
2021-12-10 |
2021-11-11 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
2.648
-11.8%
35,69
94.507 USD
|
2.648
-11.8%
|
35,69
|
94.507 USD
|
|
|
2021-10-19 |
2021-10-18 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
500
+5.7%
30,70
15.350 USD
|
500
+5.7%
|
30,70
|
15.350 USD
|
|
|
2021-10-15 |
2021-10-13 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
400
+4.8%
29,69
11.876 USD
|
400
+4.8%
|
29,69
|
11.876 USD
|
|
|
2021-10-14 |
2021-10-13 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
3.000
-4.8%
29,69
89.070 USD
|
3.000
-4.8%
|
29,69
|
89.070 USD
|
|
|
2021-10-12 |
2021-10-11 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
2.647
-11.8%
30,78
81.475 USD
|
2.647
-11.8%
|
30,78
|
81.475 USD
|
|
|
2021-09-29 |
2021-09-27 |
V
Verkauf
|
COLUMN GROUP II, LP
Large shareholder
|
625
-100.0%
34,94
21.840 USD
|
625
-100.0%
|
34,94
|
21.840 USD
|
|
|
2021-09-29 |
2021-09-27 |
V
Verkauf
|
COLUMN GROUP II, LP
Large shareholder
|
1.114
-100.0%
34,97
38.951 USD
|
1.114
-100.0%
|
34,97
|
38.951 USD
|
|
|
2021-09-29 |
2021-09-27 |
V
Verkauf
|
COLUMN GROUP II, LP
Large shareholder
|
7.500
-100.0%
34,48
258.606 USD
|
7.500
-100.0%
|
34,48
|
258.606 USD
|
|
|
2021-09-14 |
2021-09-13 |
V
Verkauf
|
COLUMN GROUP II, LP
Large shareholder
|
4.788
-11.6%
35,28
168.942 USD
|
4.788
-11.6%
|
35,28
|
168.942 USD
|
|
|
2021-09-14 |
2021-09-13 |
V
Verkauf
|
COLUMN GROUP II, LP
Large shareholder
|
4.726
-6.1%
35,27
166.692 USD
|
4.726
-6.1%
|
35,27
|
166.692 USD
|
|
|
2021-09-14 |
2021-09-13 |
V
Verkauf
|
COLUMN GROUP II, LP
Large shareholder
|
4.803
-6.2%
35,25
169.309 USD
|
4.803
-6.2%
|
35,25
|
169.309 USD
|
|
|
2021-09-14 |
2021-09-10 |
V
Verkauf
|
COLUMN GROUP II, LP
Large shareholder
|
7.231
-14.9%
35,19
254.494 USD
|
7.231
-14.9%
|
35,19
|
254.494 USD
|
|
|
2021-09-14 |
2021-09-10 |
V
Verkauf
|
COLUMN GROUP II, LP
Large shareholder
|
7.320
-8.7%
35,19
257.573 USD
|
7.320
-8.7%
|
35,19
|
257.573 USD
|
|
|
2021-09-14 |
2021-09-10 |
V
Verkauf
|
COLUMN GROUP II, LP
Large shareholder
|
7.187
-8.5%
35,19
252.940 USD
|
7.187
-8.5%
|
35,19
|
252.940 USD
|
|
|
2021-09-13 |
2021-09-10 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
2.648
-11.8%
35,78
94.745 USD
|
2.648
-11.8%
|
35,78
|
94.745 USD
|
|
|
2021-06-21 |
2021-06-16 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
5
+1.7%
31,61
158 USD
|
5
+1.7%
|
31,61
|
158 USD
|
|
|
2021-06-21 |
2021-06-16 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
100
+1.5%
31,53
3.153 USD
|
100
+1.5%
|
31,53
|
3.153 USD
|
|
|
2021-06-21 |
2021-06-16 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
100
+1.5%
31,56
3.156 USD
|
100
+1.5%
|
31,56
|
3.156 USD
|
|
|
2021-06-21 |
2021-06-16 |
K
Kauf
|
Robbins Wendye
Nicht geschäftsführender Verwaltungsratsmitglied
|
500
+8.2%
31,54
15.770 USD
|
500
+8.2%
|
31,54
|
15.770 USD
|
|
|
2021-06-17 |
2021-06-15 |
GV
Geplanter Verkauf
|
HO WILLIAM
Chief Medical Officer
Führungsperson
|
1.000
-1.7%
43,26
43.260 USD
|
1.000
-1.7%
|
43,26
|
43.260 USD
|
|
|
2021-06-15 |
2021-06-11 |
GV
Geplanter Verkauf
|
Brockstedt Dirk G.
Chief Scientific Officer
Führungsperson
|
2.647
-11.8%
18,55
49.102 USD
|
2.647
-11.8%
|
18,55
|
49.102 USD
|
|
